Valuation: Cegedim

Market Cap 144M 166M 135M 124M 233M 15.81B 237M 1.59B 622M 7.89B 623M 609M 26.01B P/E 2026 *
6.89x
P/E 2027 * 5.25x
Enterprise Value 306M 352M 286M 263M 495M 33.6B 504M 3.37B 1.32B 16.75B 1.32B 1.29B 55.26B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+2.00%
1 week+2.72%
Current month+2.00%
3 months-10.92%
6 months-23.02%
Current year-24.16%
1 week 9.97
Extreme 9.97
10.2
1 month 9.73
Extreme 9.73
10.42
Current year 8.7
Extreme 8.7
14.15
1 year 8.7
Extreme 8.7
14.15
3 years 8.7
Extreme 8.7
21
5 years 8.7
Extreme 8.7
29.25
10 years 8.7
Extreme 8.7
42.7
Manager TitleAgeSince
Chief Executive Officer 83 24/10/2009
Director of Finance/CFO - 13/06/2016
Corporate Officer/Principal 55 25/11/2015
Director TitleAgeSince
Chairman 83 24/10/2009
Director/Board Member 72 08/08/2010
Director/Board Member 55 25/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+2.72% - - 160M
+9.22%+18.31%-41.96%+23.83% 374B
+4.41%+8.83%-32.70%+36.20% 209B
+2.66%+8.18%-37.56%+1.88% 115B
-0.56%+5.84%-36.35%+12.70% 45.36B
+1.69%-3.84%-74.13%+143.29% 35.87B
-6.90%-18.36%-24.30%+22.25% 24.25B
+1.61%+6.32%-29.73%+58.64% 18.71B
+2.14%+3.62%-30.07%+4.11% 13.19B
+3.55%+5.39%-29.41%+88.35% 12.65B
Average +0.76%+5.09%-37.36%+43.47% 94.28B
Weighted average by Cap. +1.47%+11.73%-39.00%+29.74%

Financials

2026 *2027 *
Net sales 660M 759M 616M 565M 1.07B 72.33B 1.08B 7.26B 2.84B 36.07B 2.85B 2.79B 119B 684M 787M 639M 586M 1.11B 75.02B 1.12B 7.53B 2.95B 37.41B 2.96B 2.89B 123B
Net income 21.3M 24.51M 19.89M 18.26M 34.42M 2.34B 35.02M 234M 91.83M 1.16B 92.06M 90.02M 3.84B 28M 32.22M 26.14M 24M 45.25M 3.07B 46.04M 308M 121M 1.53B 121M 118M 5.05B
Net Debt 162M 187M 151M 139M 262M 17.78B 267M 1.79B 699M 8.87B 701M 685M 29.25B 134M 154M 125M 115M 216M 14.67B 220M 1.47B 577M 7.32B 578M 565M 24.13B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change
03/08/26 €10.20 +2.00%
31/07/26 €10.00 +0.30%
30/07/26 €9.970 0.00%
29/07/26 €9.970 +0.61%
28/07/26 €9.910 -0.20%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.50EUR
Average target price
15.50EUR
Spread / Average Target
+47.62%

Quarterly revenue - Rate of surprise